Latest Insider Transactions at Coya Therapeutics, Inc. (COYA)
This section provides a real-time view of insider transactions for Coya Therapeutics, Inc. (COYA). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Coya Therapeutics, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Coya Therapeutics, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Aug 22
2023
|
Ann Lee Director |
BUY
Open market or private purchase
|
Indirect |
1,000
+5.41%
|
$3,000
$3.62 P/Share
|
|
Jan 03
2023
|
Dov A Md Goldstein Director |
BUY
Open market or private purchase
|
Direct |
10,000
+50.0%
|
-
|
|
Jan 03
2023
|
Anabella Villalobos Director |
BUY
Open market or private purchase
|
Direct |
10,000
+50.0%
|
-
|
|
Jan 03
2023
|
David S Snyder Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
7,000
+50.0%
|
-
|
|
Jan 03
2023
|
Hideki Garren Director |
BUY
Open market or private purchase
|
Direct |
2,000
+50.0%
|
-
|
|
Jan 03
2023
|
Adrian Hepner Chief Medical Officer |
BUY
Open market or private purchase
|
Direct |
10,000
+50.0%
|
-
|
|
Jan 03
2023
|
Ann Lee Director |
BUY
Conversion of derivative security
|
Direct |
6,479
+28.22%
|
$25,916
$4.0 P/Share
|
|
Jan 03
2023
|
Ann Lee Director |
BUY
Open market or private purchase
|
Direct |
10,000
+50.0%
|
-
|
|
Jan 03
2023
|
Howard Berman Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
10,000
+50.0%
|
-
|